Aardvark Therapeutics (AARD) Research & Development (2024 - 2026)
Aardvark Therapeutics' Research & Development was $10.46 million in Q2 2026, down 20.5% from $13.15 million a year earlier and down 36.9% from the prior quarter.
Powered by 
Analysis
Aardvark Therapeutics (AARD) Research & Development (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aardvark Therapeutics' Research & Development was $55.06 million through Jun 30, 2026, up 66.7% year-over-year; for FY2025, it was $48.94 million, up 181.8% from FY2024.
- In earlier years, Research & Development was $17.36 million in FY2024.
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q1 2025.
- Compared with a year earlier, Research & Development was higher in five of the last six quarters, with growth averaging 196.2%.
- Per Business Quant data, AARD's Research & Development in the three quarters before Q2 2026 was $16.57 million (Q1 2026), $14.3 million (Q4 2025) and $13.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Aardvark Therapeutics | 115.33 Mn | 41.43 Mn | - | 10.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.46 Mn |
| Mar 31, 2026 | 16.57 Mn |
| Dec 31, 2025 | 14.30 Mn |
| Sep 30, 2025 | 13.74 Mn |
| Jun 30, 2025 | 13.15 Mn |
| Mar 31, 2025 | 7.76 Mn |
| Dec 31, 2024 | 8.06 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.03 Mn |
| Mar 31, 2024 | 1.21 Mn |
API Access
Aardvark Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AARD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AARD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AARD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();